Common Stock, Shares Authorized of Chemomab Therapeutics Ltd. from 30 Jun 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Chemomab Therapeutics Ltd. quarterly Common Stock, Shares Authorized in shares history and change rate from 30 Jun 2018 to 30 Jun 2025.
  • Chemomab Therapeutics Ltd. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 4,650,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 4,650,000,000 0 0% 30 Jun 2025 6-K 14 Aug 2025 2025 Q2
Q4 2024 4,650,000,000 +4,000,000,000 +615% 31 Dec 2024 6-K 14 Aug 2025 2025 Q2
Q2 2024 4,650,000,000 +4,000,000,000 +615% 30 Jun 2024 6-K 21 Aug 2024 2024 Q2
Q4 2023 650,000,000 0 0% 31 Dec 2023 20-F 04 Apr 2025 2024 FY
Q2 2023 650,000,000 0 0% 30 Jun 2023 6-K 14 Aug 2023 2023 Q2
Q1 2023 650,000,000 0 0% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 650,000,000 0 0% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q3 2022 650,000,000 0 0% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 650,000,000 0 0% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 650,000,000 0 0% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 650,000,000 +150,000,000 +30% 31 Dec 2021 20-F 28 Mar 2024 2023 FY
Q3 2021 650,000,000 +150,000,000 +30% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 650,000,000 +150,000,000 +30% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 650,000,000 +550,000,000 +550% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 500,000,000 +400,000,000 +400% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 500,000,000 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 500,000,000 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 100,000,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 100,000,000 0 0% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q4 2018 100,000,000 31 Dec 2018 10-K 17 Mar 2020 2019 FY
Q2 2018 30,000,000 30 Jun 2018 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.